Diabetic Nephropathy: Lessons From the Mouse

REFERENCES

1. ↵
   1. Mitch WE

   (11 4, 2004) Treating diabetic nephropathy—are there only economic issues. N Engl J Med 351(19):1934–1936, pmid:15516698, Epub 2004 Oct 31.

   OpenUrlCrossRefPubMed
2. ↵
   1. Brenner BM

   (12, 2002) Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest 110(12):1753–1758, pmid:12488422.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Huang W,
   2. Gallois Y,
   3. Bouby N,
   4. et al.

   (11 6, 2001) Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci U S A 98(23):13330–13334, pmid:11687636, Epub 2001 Oct 30.

   OpenUrlAbstract/FREE Full Text
4. ↵
   1. Kakoki M,
   2. Takahashi N,
   3. Jennette JC,
   4. Smithies O

   (9 7, 2004) Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A 101(36):13302–13305, pmid:15326315, Epub 2004 Aug 23.

   OpenUrlAbstract/FREE Full Text
5. 1. Kakoki M,
   2. Kizer CM,
   3. Yi X,
   4. et al.

   (5, 2006) Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest 116(5):1302–1309, pmid:16604193, Epub 2006 Apr 6.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Kakoki M,
   2. McGarrah RW,
   3. Kim HS,
   4. Smithies O

   (5 1, 2007) Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 104(18):7576–7581, pmid:17452647, Epub 2007 Apr 23.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Brownlee M

   (6, 2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54(6):1615–1625, pmid:15919781.

   OpenUrlFREE Full Text
8. 1. Lee HB,
   2. Yu MR,
   3. Yang Y,
   4. Jiang Z,
   5. Ha H

   (8, 2003) Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14(8 Suppl 3):S241–S245, pmid:12874439.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Li JM,
   2. Shah AM

   (8, 2003) ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14(8 Suppl 3):S221–S226, pmid:12874435.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Deltour L,
    2. Vandamme J,
    3. Jouvenot Y,
    4. et al.

    (12, 2004) Differential expression and imprinting status of Ins1 and Ins2 genes in extraembryonic tissues of laboratory mice. Gene Expr Patterns 5(2):297–300, pmid:15567729.

    OpenUrlCrossRefPubMed
11. ↵
    1. Kang BP,
    2. Urbonas A,
    3. Baddoo A,
    4. Baskin S,
    5. Malhotra A,
    6. Meggs LG

    (11, 2003) IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose. Am J Physiol Renal Physiol 285(5):F1013–F1024, pmid:12876069, Epub 2003 Jul 22.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Yang S,
    2. Chintapalli J,
    3. Sodagum L,
    4. et al.

    (11, 2005) Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol 289(5):F1144–F1152, pmid:15956778, Epub 2005 Jun 14.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Migliaccio E,
    2. Giorgio M,
    3. Mele S,
    4. et al.

    (11 18, 1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402(6759):309–313, pmid:10580504.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Zhou S,
    2. Chen HZ,
    3. Wan YZ,
    4. et al.

    (9 2, 2011) Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 109(6):639–648, pmid:21778425, Epub 2011 Jul 21.

    OpenUrlAbstract/FREE Full Text